- Home
- CVRX vs SOPH Comparison
CVRX vs SOPH Comparison
Compare CVRX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- SOPH
- Stock Information
- Founded
- CVRX 2000
- SOPH 2011
- Country
- CVRX United States
- SOPH Switzerland
- Employees
- CVRX N/A
- SOPH N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVRX Health Care
- SOPH Health Care
- Exchange
- CVRX Nasdaq
- SOPH Nasdaq
- Market Cap
- CVRX 174.4M
- SOPH 193.8M
- IPO Year
- CVRX 2021
- SOPH 2021
- Fundamental
- Price
- CVRX $5.89
- SOPH $3.04
- Analyst Decision
- CVRX Buy
- SOPH Strong Buy
- Analyst Count
- CVRX 7
- SOPH 2
- Target Price
- CVRX $14.50
- SOPH $6.50
- AVG Volume (30 Days)
- CVRX 232.7K
- SOPH 83.3K
- Earning Date
- CVRX 07-28-2025
- SOPH 08-05-2025
- Dividend Yield
- CVRX N/A
- SOPH N/A
- EPS Growth
- CVRX N/A
- SOPH N/A
- EPS
- CVRX N/A
- SOPH N/A
- Revenue
- CVRX $52,870,000.00
- SOPH $67,173,000.00
- Revenue This Year
- CVRX $11.53
- SOPH $16.07
- Revenue Next Year
- CVRX $18.61
- SOPH $22.94
- P/E Ratio
- CVRX N/A
- SOPH N/A
- Revenue Growth
- CVRX 25.62
- SOPH 4.66
- 52 Week Low
- CVRX $4.30
- SOPH $2.58
- 52 Week High
- CVRX $18.55
- SOPH $5.00
- Technical
- Relative Strength Index (RSI)
- CVRX 41.15
- SOPH 53.60
- Support Level
- CVRX $5.54
- SOPH $2.80
- Resistance Level
- CVRX $5.96
- SOPH $3.08
- Average True Range (ATR)
- CVRX 0.40
- SOPH 0.23
- MACD
- CVRX -0.03
- SOPH 0.01
- Stochastic Oscillator
- CVRX 21.99
- SOPH 61.64
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.